glp-1 for anxiety The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Role of Central Glucagon-like Peptide-1

10.1158/1078-0432.CCR-06-0818 151 PitoiaF.JerkovichF

It does not cover prescription GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro), which work through entirely different mechanisms and have substantially more clinical evidence

After 12 weeks, you can increase the dosage if needed

A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity

It makes it an adjunct with a plausible mechanism and thin outcome data, delivered inside a supervised programme

Recommendations: Mix 1 scoop in 6 oz of water and consume first thing in the morning and again later in the afternoon